Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip R Johnson

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Microbiology Spectrum|June 25, 2015
Vector-Mediated In Vivo Antibody ExpressionBruce C Schnepp, Philip R Johnson
Current Topics in Microbiology and Immunology|December 24, 2013
Gene-based vaccine approaches for respiratory syncytial virusRebecca J Loomis, Philip R Johnson
Current Opinion in HIV and AIDS|March 19, 2014
Adeno-associated virus delivery of broadly neutralizing antibodiesBruce C Schnepp, Philip R Johnson
Vaccines|September 8, 2015
Emerging Vaccine TechnologiesRebecca J Loomis, Philip R Johnson
Advances in Experimental Medicine and Biology|March 12, 2015
Vector-mediated antibody gene transfer for infectious diseasesBruce C Schnepp, Philip R Johnson
Annual Review of Virology|June 25, 2017
Engineered Expression of Broadly Neutralizing Antibodies Against Human Immunodeficiency VirusMaham Ahmad, Osama M Ahmed, Bruce Schnepp, et al.
Lancet (London, England)|November 30, 2004
An AIDS vaccine: no time to give upDennis R Burton, Ronald C Desrosiers, Philip R Johnson, et al.
Journal of Virology|November 21, 2008
Infectious molecular clones of adeno-associated virus isolated directly from human tissuesBruce C Schnepp, Ryan L Jensen, K Reed Clark, et al.
The Journal of Infectious Diseases|September 1, 2007
Dynamics of simian immunodeficiency virus populations in blood and cerebrospinal fluid over the full course of infectionPatrick R Harrington, Mary J Connell, Rick B Meeker, et al.
Journal of Virology|August 7, 2002
Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transferAnne D Lewis, Ruju Chen, David C Montefiori, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Microbiology Spectrum|June 25, 2015
Vector-Mediated In Vivo Antibody ExpressionBruce C Schnepp, Philip R Johnson
Current Topics in Microbiology and Immunology|December 24, 2013
Gene-based vaccine approaches for respiratory syncytial virusRebecca J Loomis, Philip R Johnson
Current Opinion in HIV and AIDS|March 19, 2014
Adeno-associated virus delivery of broadly neutralizing antibodiesBruce C Schnepp, Philip R Johnson
Vaccines|September 8, 2015
Emerging Vaccine TechnologiesRebecca J Loomis, Philip R Johnson
Advances in Experimental Medicine and Biology|March 12, 2015
Vector-mediated antibody gene transfer for infectious diseasesBruce C Schnepp, Philip R Johnson
Annual Review of Virology|June 25, 2017
Engineered Expression of Broadly Neutralizing Antibodies Against Human Immunodeficiency VirusMaham Ahmad, Osama M Ahmed, Bruce Schnepp, et al.
Lancet (London, England)|November 30, 2004
An AIDS vaccine: no time to give upDennis R Burton, Ronald C Desrosiers, Philip R Johnson, et al.
Journal of Virology|November 21, 2008
Infectious molecular clones of adeno-associated virus isolated directly from human tissuesBruce C Schnepp, Ryan L Jensen, K Reed Clark, et al.
The Journal of Infectious Diseases|September 1, 2007
Dynamics of simian immunodeficiency virus populations in blood and cerebrospinal fluid over the full course of infectionPatrick R Harrington, Mary J Connell, Rick B Meeker, et al.
Journal of Virology|August 7, 2002
Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transferAnne D Lewis, Ruju Chen, David C Montefiori, et al.
Pageof 4